Top Stocks for Tomorrow Trading By Technical Analyst ( 12 Sep 2017 )

Research Head (MONEY MAKER RESEARCH & INVESTMENT ADVISOR PVT LTD) is having a view that one can go long in PANACEA BIOTECH.

“PANACEA BIOTECH is looking bullish on Daily Charts & Bullish crossover in MACD and strong reading at ADX shows strong trend, therefore I recommend traders to go long around 266 with a price target of around 276 & Stop loss should be placed below 251”

The company has product portfolio that caters therapeutics areas like pain management, diabetes and cardiovascular management, renal disease management, osteoporosis management, anti-tubercular, gastro-intestinal. Panacea Biotec is the third largest biotechnology company (as per ABLE Survey, 2006), as well as among the top 50 pharmaceutical companies (as per ORG IMS July 2006) of India. The company has been granted patents across countries like USA, U.K., France, Germany, Italy, Sweden, Denmark, Spain, Finland, Switzerland, The Netherlands, New Zealand, Mexico, Brazil, Nigeria, Zimbabwe, Australia, South Africa, Japan, Russia, Canada, Ukraine, Korea and China are among others.

The company expanded its existing collaboration with Apotex Inc, the largest Canadian-owned pharmaceutical company, for sales & distribution of Prasugrel 5mg and 10mg tablets in the USA.

It has signed an exclusive license and supply agreement with Apotex for this purpose.

Stock has been gaining for the last 3 days and has risen 29.05% in the period

Free Stock Tips for Today (12th September) - Money Maker Research

Key indices were hovering in positive territory after hitting fresh intraday high in early trade. The BSE Sensex was trading at 32,050 up 168 points, while Nifty hit at 10,052 up 46 points.

Stocks of Future Consumer lost 1.12% to Rs 66.10 late morning hours on BSE, with the stock sliding on profit booking after recent strong rally. The stock had hit a high and low of Rs 67.95 and Rs 63.70, respectively during the day. 

L&T hits 52-week high after winning order, Stocks of L&T rose 0.42% to Rs 1,222 on BSE after the company said that its construction division won orders of Rs 2525 crore. The stock had hit a high of Rs 1231.95 and a low of Rs 1,219 so far during the day.

Stocks of Strides Shasun Ltd is trading higher Rs. 27.30, at Rs. 968.60 on BSE after the company announced it has obtained approval from the US Food & Drug Administration for its Potassium Citrate extended-release tablets for treatment of certain types of kidney stones.

Stocks of Godrej Industries Ltd rose 3.2%, Godrej Properties Ltd surged 5%, Godrej Consumer Products Ltd rose 1.3%. Godrej Agrovet unit of Godrej Industries Limited received approval from Sebi to raise Rs 1200 crore via IPO.

SEBI Introduces Physical Settlement in Derivative Segment - Money Maker Research

The market regulator SEBI is on the lookout of introducing physical-based settlement in the equity derivatives sector, which aims to reduce the disproportionate market speculation in the F&O market and to boost govt taxes by encouraging cash market trade, as per news.

In physical settlement, a buyer or seller of Future & Option contracts has the option to seek delivery of shares if the speculator tries to artificially enhance or suppress derivative prices. Presently, stock markets follow cash settlement, in which the Future & Option contract is settled by paying the difference between strike price and the value of underlying security, which is tend to manipulation.

In stock market trading, generally, there are two kinds of derivative contracts viz. futures and options. A futures contract implies a legally binding agreement to buy or sell the underlying security on a future date, whereas options contract offers the buyer or holder of the contract the right, but not the obligation, to buy or sell the underlying asset at a pre-determined price within or at end of a specified period. The buyers of a stock futures is not buying an underlying stock but merely an option to buy at a future date, which they seldom exercises, therefore the ‘cash settled’ futures transaction is necessitates no ownership obligation. 

India has come out as the second most speculative markets worldwide after South Korea. This has made the govt and SEBI to step on a path of caution. Moreover, it is expected that any surge in cash volumes in the derivative segment is possibly to give remarkable thrust to STT collection.